Bioorganic and Medicinal Chemistry Letters p. 2691 - 2696 (2001)
Update date:2022-08-05
Topics:
Barrow, James C
Nantermet, Philippe G
Selnick, Harold G
Glass, Kristen L
Ngo, Phung L
Young, Mary Beth
Pellicore, Janetta M
Breslin, Michael J
Hutchinson, John H
Freidinger, Roger M
Condra, Cindra
Karczewski, Jerzy
Bednar, Rodney A
Gaul, Stanley L
Stern, Andrew
Gould, Robert
Connolly, Thomas M
Thrombin is the most potent agonist of platelet activation, and its effects are predominantly mediated by platelet thrombin receptors. Therefore, antagonists of the thrombin receptor have potential utility for the treatment of thrombotic disorders. Screening of combinatorial libraries revealed 2 to be a potent antagonist of the thrombin receptor. Modifications of this structure produced 11k, which inhibits thrombin receptor stimulated secretion and aggregation of platelets.
View MoreDalian Synco Chemical Co., Ltd.
Contact:+86-411-83635150
Address:Rm 1004, 24, Tangshan Street, Dalian
website:http://www.truewingroup.com
Contact:86-311-66699812
Address:NO.600 ZHONGSHAN EAST ROAD SHIJIAZHUANG
Huludao Tianqi Shengye Chemical Co.,Ltd.
Contact:0086 429 2075777
Address:Area B,Shipbuilding Industry Park,Beigang District,Huludao City,Liaoning prov.,China
Changzhou Ansciep Chemical Co.,Ltd.
Contact:+86 519 8630 5871
Address:A-710 Boan International, 8 East Guangdian Road,Wujin,Changzhou
Shanghai Standard Biotech Co., Ltd.
Contact:+86-18502101150
Address:Room 103, Building 2nd, NO.720, Cailun Road , Pudong District, Shanghai, China
Doi:10.1016/S0008-6215(00)90386-0
(1986)Doi:10.1021/acs.joc.1c01090
(2021)Doi:10.1021/jo00952a042
(1973)Doi:10.3390/molecules23081859
(2018)Doi:10.1021/ol0167614
(2001)Doi:10.1039/c5cc04009d
(2015)